Find out more about the TOP Factor, an alternative metric to the impact factor, evaluating academic journals based on open science policies.
Find out more about ISMPP’s guidance for navigating author non-responsiveness in the wake of the coronavirus pandemic.
Find out why guidance is needed and what’s covered in the new Synthesis Without Meta-analysis (SWiM) guidelines.
PLOS ONE now offers Registered Reports, shifting peer review focus from results to the quality of study design. Is this part of the future of open science?
Find out more about the impact the new ICMJE disclosure form will have on authors publishing in medical journals.
With widespread and growing support for increased data sharing, what can we learn from the Yale Open Data Access (YODA) Project and its collaboration with Johnson & Johnson?
Many journals ask submitting authors to suggest recommended peer reviewers, potentially risking bias and misconduct. Do the benefits outweigh these risks?
We summarise the key changes to the ICMJE recommendations for authors and medical publication professionals.
Abstract ‘spin’ can distort a study’s findings and lead to inappropriate conclusions being drawn. But just how prevalent is this problem?
[VIDEO] Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment
Gemma Rogers, Communications Director at Oxford Pharmagenesis, discusses a study on clinical trial transparency.
[VIDEO] Professional medical writing support and the quality, ethics and timeliness of clinical trial reporting: a systematic review
Obaro Evuarherhe, Principal Consultant at Oxford PharmaGenesis, discusses professional medical writing support and the quality, ethics and timeliness of clinical trial reporting.
A new tool from MPIP provides easily accessible information on open access options for industry-funded research.
Does professional medical writing support impact the quality, ethics and timeliness of clinical trial reporting?
Findings of a systematic review show working with professional medical writers positively affects measures of quality, ethics and timeliness.
A recent article from Nature news delves into clinical trial reporting following evidence showing that some universities are failing to meet EU regulations.
Join CBI for the latest updates on data sharing, collaborating with patients and innovations in publishing.
Discover the five areas for improvement identified in Springer Nature’s recent surveys of researchers, aiming to promote data sharing.